P-381: Talquetamab Utilization Patterns and Dose Schedules in the United States: A Real-World Analysis

Discussant(s)

• 

  P.Joy Ho, MBBS DPhil FRACP FRCPA

  Director
  Institute of Haematology, Royal Prince Alfred Hospital
  Camperdown, New South Wales, Australia

Poster Presenter(s)

• 

  Rahul Banerjee, MD (he/him/his)

  Assistant Professor
  Fred Hutchinson Cancer Center
  Seattle, Washington, United States